Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening

M Arbyn, J Dillner - Journal of Clinical Virology, 2007 - Elsevier
The recognition of a strong etiological relationship between infection with high-risk human
papillomavirusses and cervical cancer has prompted research to develop and evaluate …

Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma

S Kamara, Y Guo, S Mao, X Ye, Q Li, M Zheng… - Applied Microbiology …, 2021 - Springer
Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV)
latent infection and is common in Southern China and Southeast Asia. The viral latent …

Perspectives for the development of human papillomavirus vaccines and immunotherapy

LG Bermudez-Humaran, P Langella - Expert Review of vaccines, 2010 - Taylor & Francis
Human papillomavirus (HPV) is the most common sexually transmitted infection and is
responsible for 90–99% of cervical cancer (CxCa) cases. Although effective screening …

Langerhans cells in cervical intraepithelial neoplasia related to smoking habits

AB Campaner, S Piato, MAL Galvão… - Journal of lower …, 2006 - journals.lww.com
Objective. Compare the numerical densities of intraepithelial Langerhans cells of uterine
cervix of women affected by cervical intraepithelial neoplasia grade 3 (CIN 3) with their …